Formulation

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 11590243
SERIAL NO

16478232

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to the formulation of adenoviral vectors in sorbitol containing compositions in combination with a further amorphous sugar, its formulation as well as a method for obtaining a dried composition.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
GLAXOSMITHKLINE BIOLOGICALS SA1330 RIXENSART

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Bourles, Erwan Rixensart, BE 3 1
Despas, Olivier Rixensart, BE 1 1
Guillaume, Delphine Rixensart, BE 1 1
Mathot, Frederic Rixensart, BE 3 1
Vasselle, Mathieu Rixensart, BE 2 1

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
3.5 Year Payment $1600.00 $800.00 $400.00 Aug 28, 2026
7.5 Year Payment $3600.00 $1800.00 $900.00 Aug 28, 2030
11.5 Year Payment $7400.00 $3700.00 $1850.00 Aug 28, 2034
Fee Large entity fee small entity fee micro entity fee
Surcharge - 3.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00